Michael Aberman

Michael Aberman, M.D. joined Regeneron in 2010 as Vice President, Strategy and Investor Relations. Prior to joining Regeneron, Dr. Aberman was a Wall Street research analyst covering the biotechnology industry in positions at Credit Suisse and Morgan Stanley. Before moving to Wall Street, Dr. Aberman was Director of Business Development at Antigenics, Inc., an oncology-focused biotechnology company. Dr. Aberman received his medical degree from the University of Toronto, completed residency training in Internal Medicine at New York Presbyterian Hospital/Weill Cornell Medical Center, and received his M.B.A. from The Wharton School of Business.